Evaluating and monitoring liver disease severity in glycogen storage disease type IX: Performance of novel and established clinical scores

Hepatic glycogen storage disease type IX (GSD IX) results from a deficiency of phosphorylase kinase. A noninvasive method of monitoring liver disease severity in this population is unavailable and liver biopsy remains the gold standard for classifying disease severity, particularly for liver fibrosis.